Operation Warp Speed commits $1.6 billion to Covid-19 vaccine maker Novavax

United States News News

Operation Warp Speed commits $1.6 billion to Covid-19 vaccine maker Novavax
United States Latest News,United States Headlines
  • 📰 CNN
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 95%

'Operation Warp Speed,' the federal government's Covid-19 vaccine program, has announced the largest government Covid-19 vaccine contract to date — a $1.6 billion contract with Novavax, a Maryland biotech company.

"Operation Warp Speed," the federal government's Covid-19 vaccine program, on Tuesday announced the largest government Covid-19 vaccine contract to date -- a $1.6 billion contract with Novavax, a Maryland biotech company.

"It speaks to the confidence that they have in our platform to be able to develop a vaccine," Stanley Erck, Novavax's president and CEO, said Monday in an interview with CNN.Erck said Novavax's vaccine could be on the market by the first quarter of next year.

Erck said he's"optimistic" that Novavax's approach will work and that his team is working"twenty-four seven" on the vaccine. "Everybody understands the importance of what we're working on. It's precedent setting," he said. In June, Novavax announced a $60 million contract with the US Department of Defense to deliver 10 million doses to the department.

"Operation Warp Speed" has the goal"to begin delivering 300 million ... doses of safe and effective vaccine to the American people in 2021," according to a Department of Health and Human Services statement issued Tuesday morning.CNN's Dana Vigue and Wes Bruer contributed to this report.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNN /  🏆 4. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax gets $1.6 billion from US's Warp Speed for coronavirus vaccine - Business InsiderNovavax gets $1.6 billion from US's Warp Speed for coronavirus vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

Novavax gets $1.6 billion from US's Warp Speed for coronavirus vaccine - Business InsiderNovavax gets $1.6 billion from US's Warp Speed for coronavirus vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

FDA leader Stephen Hahn stops short of Trump promises on vaccine timingFDA leader Stephen Hahn stops short of Trump promises on vaccine timingA recent poll showed 27% of adults are unlikely to accept a free COVID-19 vaccine, FDA Commissioner Stephen Hahn tells martharaddatz 'It is concerning... [FDA] will do our job to assess the safety and the efficacy of a vaccine candidate.'
Read more »

FDA Commissioner Stephen Hahn won’t confirm Trump’s promises on vaccine timingFDA Commissioner Stephen Hahn won’t confirm Trump’s promises on vaccine timingFDA Commissioner Stephen Hahn stops short of backing Pres. Trump's timeline suggesting a COVID-19 vaccine could be available “long before the end of the year,' telling MarthaRaddatz, 'I can't predict when a vaccine will be available.'
Read more »

Novavax skyrockets after US government grants $1.6 billion for coronavirus vaccine creation | Markets InsiderNovavax skyrockets after US government grants $1.6 billion for coronavirus vaccine creation | Markets InsiderNovavax shares spiked as much as 38% early Tuesday after receiving $1.6 billion in coronavirus vaccine funding from the US government. The award...
Read more »

U.S. government awards Novavax $1.6 billion for coronavirus vaccineU.S. government awards Novavax $1.6 billion for coronavirus vaccineThe U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Read more »



Render Time: 2025-04-01 12:13:47